Strategic investments Novo Holdings is a major life sciences investor with a broad portfolio and active funds across Seeds, Venture, Principal and Planetary Health. This signals openness to partner with innovative biotech, medical device and digital health startups at multiple stages.

Philanthropic capital As the wealth manager for the Novo Nordisk Foundation, Novo Holdings can mobilize patient and philanthropic capital in support of scalable health initiatives, enabling collaborations that blend risk-sharing with mission-driven outcomes.

Global growth Recent investments in ForYou Medical, Crystalys Therapeutics, HST Pathways and others indicate a focus on international growth, wound care, inflammation and health tech platforms, signaling opportunities for partnerships or co-investments in high-potential regions.

Technology enablers The tech stack including Apache Kafka, Databricks, Power BI, UiPath and AI-focused tools suggests a capability to leverage data platforms, automation and analytics services, making them receptive to modern data, AI and process automation solutions.

Sustainability angle Active involvement in planetary health investments and impact-focused fundraising discussions points to openness to solutions that align health outcomes with environmental, social and governance impact, offering sellers a pathway to value-aligned partnerships.